clinical trial · NCT05796453
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
Alcon Research·N/A·active not recruiting·n = 470
AphakiaAstigmatismPresbyopiaClareon Vivity IOL - Non ToricClareon Vivity IOL - ToricClareon PanOptix Trifocal IOL - Non ToricClareon PanOptix Trifocal IOL - Toric
brief summary
The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.
started
Sep 19, 2023
primary completion
Jun 1, 2028
completion
Jun 1, 2028
last updated
Aug 14, 2025
detailed description
Subjects will be recruited from a population that has already undergone lens implantation. Retrospective data will be collected from the pre-operative and surgical visits and any safety outcomes reported prior to enrollment. Prospective data will be collected from time of study enrollment through the Year 3 follow-up visit.
official title
Long-term Evaluation of Safety and Performance of Clareon Presbyopia-Correcting Intraocular Lenses (IOLs)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol